Literature DB >> 27145229

Strict Regiospecificity of Human Epithelial 15-Lipoxygenase-2 Delineates Its Transcellular Synthesis Potential.

Abigail R Green1, Shannon Barbour1, Thomas Horn1, Jose Carlos1, Jevgenij A Raskatov1, Theodore R Holman1.   

Abstract

Lipoxins are an important class of lipid mediators that induce the resolution of inflammation and arise from transcellular exchange of arachidonic acid (AA)-derived lipoxygenase products. Human epithelial 15-lipoxygenase-2 (h15-LOX-2), the major lipoxygenase in macrophages, has exhibited strict regiospecificity, catalyzing only the hydroperoxidation of carbon 15 of AA. To determine the catalytic potential of h15-LOX-2 in transcellular synthesis events, we reacted it with the three lipoxygenase-derived monohydroperoxy-eicosatetraenoic acids (HPETE) in humans: 5-HPETE, 12-HPETE, and 15-HPETE. Only 5-HPETE was a substrate for h15-LOX-2, and the steady-state catalytic efficiency (kcat/Km) of this reaction was 31% of the kcat/Km of AA. The only major product of h15-LOX-2's reaction with 5-HPETE was the proposed lipoxin intermediate, 5,15-dihydroperoxy-eicosatetraenoic acid (5,15-diHPETE). However, h15-LOX-2 did not react further with 5,15-diHPETE to produce lipoxins. This result is consistent with the specificity of h15-LOX-2 despite the increased reactivity of 5,15-diHPETE. Density functional theory calculations determined that the radical, after abstracting the C10 hydrogen atom from 5,15-diHPETE, had an energy 5.4 kJ/mol lower than that of the same radical generated from AA, demonstrating the facility of 5,15-diHPETE to form lipoxins. Interestingly, h15-LOX-2 does react with 5S,6R-diHETE, forming LipoxinA4, indicating the gemdiol does not prohibit h15-LOX-2 reactivity. Taken together, these results demonstrate the strict regiospecificity of h15-LOX-2 that circumscribes its role in transcellular synthesis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27145229      PMCID: PMC5657383          DOI: 10.1021/acs.biochem.5b01339

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  65 in total

1.  Integration of pro-inflammatory cytokines, 12-lipoxygenase and NOX-1 in pancreatic islet beta cell dysfunction.

Authors:  Jessica R Weaver; Theodore R Holman; Yumi Imai; Ajit Jadhav; Victor Kenyon; David J Maloney; Jerry L Nadler; Ganesha Rai; Anton Simeonov; David A Taylor-Fishwick
Journal:  Mol Cell Endocrinol       Date:  2012-03-20       Impact factor: 4.102

2.  12- and 15-lipoxygenases in human carotid atherosclerotic lesions: associations with cerebrovascular symptoms.

Authors:  Karl Gertow; Elena Nobili; Lasse Folkersen; John W Newman; Theresa L Pedersen; Johan Ekstrand; Jesper Swedenborg; Hartmut Kühn; Craig E Wheelock; Göran K Hansson; Ulf Hedin; Jesper Z Haeggström; Anders Gabrielsen
Journal:  Atherosclerosis       Date:  2011-01-21       Impact factor: 5.162

3.  Coactosin-like protein supports 5-lipoxygenase enzyme activity and up-regulates leukotriene A4 production.

Authors:  Marija Rakonjac; Lutz Fischer; Patrick Provost; Oliver Werz; Dieter Steinhilber; Bengt Samuelsson; Olof Rådmark
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-21       Impact factor: 11.205

4.  Substrate specificity changes for human reticulocyte and epithelial 15-lipoxygenases reveal allosteric product regulation.

Authors:  Aaron T Wecksler; Victor Kenyon; Joshua D Deschamps; Theodore R Holman
Journal:  Biochemistry       Date:  2008-06-21       Impact factor: 3.162

5.  5-lipoxygenase-activating protein stimulates the utilization of arachidonic acid by 5-lipoxygenase.

Authors:  M Abramovitz; E Wong; M E Cox; C D Richardson; C Li; P J Vickers
Journal:  Eur J Biochem       Date:  1993-07-01

6.  Expression and regulation of 12/15-lipoxygenases in human primary macrophages.

Authors:  Sophia J A Wuest; Margot Crucet; Claudio Gemperle; Christa Loretz; Martin Hersberger
Journal:  Atherosclerosis       Date:  2012-08-23       Impact factor: 5.162

7.  Kinetic and structural investigations of the allosteric site in human epithelial 15-lipoxygenase-2.

Authors:  Aaron T Wecksler; Victor Kenyon; Natalie K Garcia; Joshua D Deschamps; Wilfred A van der Donk; Theodore R Holman
Journal:  Biochemistry       Date:  2009-09-15       Impact factor: 3.162

8.  Double dioxygenation of arachidonic acid by soybean lipoxygenase-1. Kinetics and regio-stereo specificities of the reaction steps.

Authors:  C P Van Os; G P Rijke-Schilder; H Van Halbeek; J Verhagen; J F Vliegenthart
Journal:  Biochim Biophys Acta       Date:  1981-01-26

9.  Evidence for a lipoxygenase mechanism in the biosynthesis of epoxide and dihydroxy leukotrienes from 15(S)-hydroperoxyicosatetraenoic acid by human platelets and porcine leukocytes.

Authors:  R L Maas; A R Brash
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

10.  ATP allosterically activates the human 5-lipoxygenase molecular mechanism of arachidonic acid and 5(S)-hydroperoxy-6(E),8(Z),11(Z),14(Z)-eicosatetraenoic acid.

Authors:  Christopher J Smyrniotis; Shannon R Barbour; Zexin Xia; Mark S Hixon; Theodore R Holman
Journal:  Biochemistry       Date:  2014-07-02       Impact factor: 3.162

View more
  7 in total

1.  5 S,15 S-Dihydroperoxyeicosatetraenoic Acid (5,15-diHpETE) as a Lipoxin Intermediate: Reactivity and Kinetics with Human Leukocyte 5-Lipoxygenase, Platelet 12-Lipoxygenase, and Reticulocyte 15-Lipoxygenase-1.

Authors:  Abigail R Green; Cody Freedman; Jennyfer Tena; Benjamin E Tourdot; Benjamin Liu; Michael Holinstat; Theodore R Holman
Journal:  Biochemistry       Date:  2018-11-15       Impact factor: 3.162

2.  PEBP1 Wardens Ferroptosis by Enabling Lipoxygenase Generation of Lipid Death Signals.

Authors:  Sally E Wenzel; Yulia Y Tyurina; Jinming Zhao; Claudette M St Croix; Haider H Dar; Gaowei Mao; Vladimir A Tyurin; Tamil S Anthonymuthu; Alexandr A Kapralov; Andrew A Amoscato; Karolina Mikulska-Ruminska; Indira H Shrivastava; Elizabeth M Kenny; Qin Yang; Joel C Rosenbaum; Louis J Sparvero; David R Emlet; Xiaoyan Wen; Yoshinori Minami; Feng Qu; Simon C Watkins; Theodore R Holman; Andrew P VanDemark; John A Kellum; Ivet Bahar; Hülya Bayır; Valerian E Kagan
Journal:  Cell       Date:  2017-10-19       Impact factor: 41.582

3.  15-Lipoxygenase-1 biosynthesis of 7S,14S-diHDHA implicates 15-lipoxygenase-2 in biosynthesis of resolvin D5.

Authors:  Steven C Perry; Chakrapani Kalyanaraman; Benjamin E Tourdot; William S Conrad; Oluwayomi Akinkugbe; John Cody Freedman; Michael Holinstat; Matthew P Jacobson; Theodore R Holman
Journal:  J Lipid Res       Date:  2020-05-13       Impact factor: 5.922

4.  Empowerment of 15-Lipoxygenase Catalytic Competence in Selective Oxidation of Membrane ETE-PE to Ferroptotic Death Signals, HpETE-PE.

Authors:  Tamil S Anthonymuthu; Elizabeth M Kenny; Indira Shrivastava; Yulia Y Tyurina; Zachary E Hier; Hsiu-Chi Ting; Haider H Dar; Vladimir A Tyurin; Anastasia Nesterova; Andrew A Amoscato; Karolina Mikulska-Ruminska; Joel C Rosenbaum; Gaowei Mao; Jinming Zhao; Marcus Conrad; John A Kellum; Sally E Wenzel; Andrew P VanDemark; Ivet Bahar; Valerian E Kagan; Hülya Bayır
Journal:  J Am Chem Soc       Date:  2018-12-17       Impact factor: 15.419

5.  Role of Human 15-Lipoxygenase-2 in the Biosynthesis of the Lipoxin Intermediate, 5S,15S-diHpETE, Implicated with the Altered Positional Specificity of Human 15-Lipoxygenase-1.

Authors:  Steven C Perry; Thomas Horn; Benjamin E Tourdot; Adriana Yamaguchi; Chakrapani Kalyanaraman; William S Conrad; Oluwayomi Akinkugbe; Michael Holinstat; Matthew P Jacobson; Theodore R Holman
Journal:  Biochemistry       Date:  2020-10-13       Impact factor: 3.162

6.  In Vitro Biosynthetic Pathway Investigations of Neuroprotectin D1 (NPD1) and Protectin DX (PDX) by Human 12-Lipoxygenase, 15-Lipoxygenase-1, and 15-Lipoxygenase-2.

Authors:  Wan-Chen Tsai; Chakrapani Kalyanaraman; Adriana Yamaguchi; Michael Holinstat; Matthew P Jacobson; Theodore R Holman
Journal:  Biochemistry       Date:  2021-05-24       Impact factor: 3.162

Review 7.  Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators-What is the Evidence so far?

Authors:  Nils Helge Schebb; Hartmut Kühn; Astrid S Kahnt; Katharina M Rund; Valerie B O'Donnell; Nicolas Flamand; Marc Peters-Golden; Per-Johan Jakobsson; Karsten H Weylandt; Nadine Rohwer; Robert C Murphy; Gerd Geisslinger; Garret A FitzGerald; Julien Hanson; Claes Dahlgren; Mohamad Wessam Alnouri; Stefan Offermanns; Dieter Steinhilber
Journal:  Front Pharmacol       Date:  2022-03-02       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.